← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
GlaxoSmithKline
-6.64%
Pharma / Pharma and biotechnology
At a Glance | Core Facts | Company | Industry | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebOverview
GlaxoSmithKline (GSK) is a multinational pharmaceutical and healthcare company headquartered in Brentford, London. The company was formed in 2000 through the merger of British company Glaxo Wellcome and American company SmithKline Beecham. It is one of the largest pharmaceutical companies in the world and is focused on the research, development, and marketing of prescription medicines, vaccines, and consumer healthcare products.
History:
The history of GlaxoSmithKline can be traced back to the establishment of two independent companies: Joseph Nathan and Co. in New Zealand in 1873 and Burroughs Wellcome & Company in the UK in 1880. In 1995, Glaxo Wellcome PLC was formed through the merger of Glaxo and Burroughs Wellcome. SmithKline Beecham PLC was formed in 1989 through the merger of SmithKline Beckman Corporation and Beecham Group PLC. In 2000, the two companies merged to form GlaxoSmithKline.
Products:
GSK's product portfolio includes prescription medicines, vaccines, and consumer healthcare products. Its prescription medicines cover a broad range of therapeutic areas, including respiratory, HIV, oncology, and neurosciences. The company also offers vaccines for diseases such as influenza, meningitis, and shingles. Its consumer healthcare products include over-the-counter medicines, oral care, nutrition, and skin health products.
Research and Development:
GSK has a strong focus on research and development (R&D) and invests heavily in this area. The company has R&D facilities in the UK, US, Belgium, and China, among others. Its R&D efforts are focused on discovering and developing new medicines and vaccines for a wide range of diseases and conditions. GSK collaborates with academic institutions, governments, and other industry partners to advance its research efforts.
Corporate Responsibility:
GSK is committed to operating ethically and responsibly, with a focus on sustainability and corporate social responsibility. The company has various initiatives in place to reduce its environmental impact and improve access to healthcare for underserved populations. It also has policies in place to ensure ethical business practices and compliance with laws and regulations.
Financials:
In 2020, GSK reported revenues of £34 billion and a net income of £5.5 billion. The company employs over 100,000 people globally and has a presence in over 150 countries. Its primary stock exchange listings are on the London Stock Exchange and the New York Stock Exchange.
Partnerships:
GSK has formed partnerships with various organizations to further its research and development efforts, expand its product portfolio, and improve access to healthcare. Some notable collaborations include:
- Joint ventures with Pfizer in the areas of consumer healthcare and HIV treatment
- Collaboration with Sanofi to develop a COVID-19 vaccine
- Partnership with Innoviva to develop respiratory treatments
- Collaboration with Vir Biotechnology to develop pandemic treatments
- Partnership with the Bill & Melinda Gates Foundation to develop vaccines for malaria and tuberculosis
Summary:
GlaxoSmithKline is a multinational pharmaceutical and healthcare company focused on research, development, and marketing of prescription medicines, vaccines, and consumer healthcare products. It has a strong history and presence in the market, with a commitment to corporate responsibility and ethical business practices. The company has a diverse range of products and partnerships that contribute to its strong financial performance.
History:
The history of GlaxoSmithKline can be traced back to the establishment of two independent companies: Joseph Nathan and Co. in New Zealand in 1873 and Burroughs Wellcome & Company in the UK in 1880. In 1995, Glaxo Wellcome PLC was formed through the merger of Glaxo and Burroughs Wellcome. SmithKline Beecham PLC was formed in 1989 through the merger of SmithKline Beckman Corporation and Beecham Group PLC. In 2000, the two companies merged to form GlaxoSmithKline.
Products:
GSK's product portfolio includes prescription medicines, vaccines, and consumer healthcare products. Its prescription medicines cover a broad range of therapeutic areas, including respiratory, HIV, oncology, and neurosciences. The company also offers vaccines for diseases such as influenza, meningitis, and shingles. Its consumer healthcare products include over-the-counter medicines, oral care, nutrition, and skin health products.
Research and Development:
GSK has a strong focus on research and development (R&D) and invests heavily in this area. The company has R&D facilities in the UK, US, Belgium, and China, among others. Its R&D efforts are focused on discovering and developing new medicines and vaccines for a wide range of diseases and conditions. GSK collaborates with academic institutions, governments, and other industry partners to advance its research efforts.
Corporate Responsibility:
GSK is committed to operating ethically and responsibly, with a focus on sustainability and corporate social responsibility. The company has various initiatives in place to reduce its environmental impact and improve access to healthcare for underserved populations. It also has policies in place to ensure ethical business practices and compliance with laws and regulations.
Financials:
In 2020, GSK reported revenues of £34 billion and a net income of £5.5 billion. The company employs over 100,000 people globally and has a presence in over 150 countries. Its primary stock exchange listings are on the London Stock Exchange and the New York Stock Exchange.
Partnerships:
GSK has formed partnerships with various organizations to further its research and development efforts, expand its product portfolio, and improve access to healthcare. Some notable collaborations include:
- Joint ventures with Pfizer in the areas of consumer healthcare and HIV treatment
- Collaboration with Sanofi to develop a COVID-19 vaccine
- Partnership with Innoviva to develop respiratory treatments
- Collaboration with Vir Biotechnology to develop pandemic treatments
- Partnership with the Bill & Melinda Gates Foundation to develop vaccines for malaria and tuberculosis
Summary:
GlaxoSmithKline is a multinational pharmaceutical and healthcare company focused on research, development, and marketing of prescription medicines, vaccines, and consumer healthcare products. It has a strong history and presence in the market, with a commitment to corporate responsibility and ethical business practices. The company has a diverse range of products and partnerships that contribute to its strong financial performance.
What is special about the company?
There are several key factors that make GlaxoSmithKline (GSK) a unique and special company:
1. Size and Scope: GSK is one of the largest pharmaceutical companies in the world, with operations in over 150 countries and a vast portfolio of products spanning prescription medicines, consumer healthcare, and vaccines.
2. History and Legacy: GSK has a rich history dating back to the 19th century, with the merger of GlaxoWellcome and SmithKline Beecham in 2000 solidifying its position as a major player in the healthcare industry.
3. Research and Development: Innovation and research are at the heart of GSK's business, with significant investments made in discovering and developing new medicines to meet unmet medical needs.
4. Commitment to Global Health: GSK's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. The company is dedicated to addressing global health challenges, such as infectious diseases and access to healthcare in developing countries.
5. Diverse Portfolio: GSK has a diverse portfolio of products, including market-leading brands such as Advair, Sensodyne, and Flonase. It also has a strong pipeline of potential new medicines and vaccines in various stages of development.
6. Corporate Responsibility: GSK is committed to conducting business responsibly and ethically, with a focus on sustainability, environmental stewardship, and improving access to healthcare for underserved populations.
7. Culture and Values: GSK prides itself on its diverse and inclusive workplace culture, guided by a set of core values that prioritize integrity, respect for people, and transparency.
Overall, GSK's size, history, focus on innovation and global health, diverse portfolio, commitment to corporate responsibility, and strong culture make it a unique and esteemed company in the pharmaceutical industry.
1. Size and Scope: GSK is one of the largest pharmaceutical companies in the world, with operations in over 150 countries and a vast portfolio of products spanning prescription medicines, consumer healthcare, and vaccines.
2. History and Legacy: GSK has a rich history dating back to the 19th century, with the merger of GlaxoWellcome and SmithKline Beecham in 2000 solidifying its position as a major player in the healthcare industry.
3. Research and Development: Innovation and research are at the heart of GSK's business, with significant investments made in discovering and developing new medicines to meet unmet medical needs.
4. Commitment to Global Health: GSK's mission is to improve the quality of human life by enabling people to do more, feel better, and live longer. The company is dedicated to addressing global health challenges, such as infectious diseases and access to healthcare in developing countries.
5. Diverse Portfolio: GSK has a diverse portfolio of products, including market-leading brands such as Advair, Sensodyne, and Flonase. It also has a strong pipeline of potential new medicines and vaccines in various stages of development.
6. Corporate Responsibility: GSK is committed to conducting business responsibly and ethically, with a focus on sustainability, environmental stewardship, and improving access to healthcare for underserved populations.
7. Culture and Values: GSK prides itself on its diverse and inclusive workplace culture, guided by a set of core values that prioritize integrity, respect for people, and transparency.
Overall, GSK's size, history, focus on innovation and global health, diverse portfolio, commitment to corporate responsibility, and strong culture make it a unique and esteemed company in the pharmaceutical industry.
What the company's business model?
GlaxoSmithKline (GSK) is a global pharmaceutical and healthcare company focused on improving the health and well-being of people around the world. The company's business model is based on four key components:
1. Research and Development (R&D): GSK invests heavily in R&D to develop new medicines, vaccines, and consumer healthcare products. The company has research centers and partnerships worldwide to drive innovation and improve patient health outcomes.
2. Commercialization and Marketing: GSK sells its products to patients, healthcare professionals, and other customers through a variety of channels. This includes traditional sales and marketing efforts, as well as digital and e-commerce initiatives.
3. Strategic Partnerships: GSK collaborates with a range of partners, including academic institutions, biotech companies, and other pharmaceutical companies, to advance its research and development efforts.
4. Diversified Portfolio: GSK operates in three main areas - pharmaceuticals, vaccines, and consumer healthcare. This diversified portfolio helps mitigate risks and allows the company to benefit from the different growth trends and regulatory landscapes across these sectors.
In addition, GSK has a strong focus on sustainability and social responsibility, integrating these principles into its business operations and decision-making. The company is also committed to pricing its products responsibly and ensuring access to medicines in developing countries.
1. Research and Development (R&D): GSK invests heavily in R&D to develop new medicines, vaccines, and consumer healthcare products. The company has research centers and partnerships worldwide to drive innovation and improve patient health outcomes.
2. Commercialization and Marketing: GSK sells its products to patients, healthcare professionals, and other customers through a variety of channels. This includes traditional sales and marketing efforts, as well as digital and e-commerce initiatives.
3. Strategic Partnerships: GSK collaborates with a range of partners, including academic institutions, biotech companies, and other pharmaceutical companies, to advance its research and development efforts.
4. Diversified Portfolio: GSK operates in three main areas - pharmaceuticals, vaccines, and consumer healthcare. This diversified portfolio helps mitigate risks and allows the company to benefit from the different growth trends and regulatory landscapes across these sectors.
In addition, GSK has a strong focus on sustainability and social responsibility, integrating these principles into its business operations and decision-making. The company is also committed to pricing its products responsibly and ensuring access to medicines in developing countries.
Interesting facts about the company
1. GlaxoSmithKline is a British multinational pharmaceutical company, with headquarters in London, England.
2. The company has a long history, dating back to a pharmacy opened by Joseph Nathan in New Zealand in 1830.
3. The company was formally founded in 1906 by Joseph Edward Nathan and his brother-in-law, Thomas Holloway, as a small pharmacy in London.
4. The name Glaxo comes from the first product that the company produced, which was a dried milk product called Glaxo.
5. Glaxo merged with Wellcome in 1995 to form Glaxo Wellcome, which then merged with SmithKline Beecham in 2000 to form GlaxoSmithKline.
6. GlaxoSmithKline is currently one of the largest pharmaceutical companies in the world, with revenue of over $41 billion in 2020.
7. The company is a major producer of vaccines, consumer healthcare products, and prescription medicines, and it has a presence in over 150 countries.
8. GlaxoSmithKline has a long history of significant scientific achievements, including the development of treatments for HIV, influenza, and malaria.
9. The company has also been involved in several high-profile legal cases, including a $3 billion settlement for illegally promoting certain drugs and a settlement with the US government for $750 million for manufacturing and quality control problems at a plant in Puerto Rico.
10. In 2020, GlaxoSmithKline became the first pharmaceutical company to pledge to make its carbon footprint net-zero by 2050.
11. GlaxoSmithKline has a strong commitment to corporate social responsibility, with a focus on improving global health, reducing its environmental impact, and supporting communities where it operates.
12. The company has a diverse workforce, with over 100,000 employees worldwide and a strong focus on diversity and inclusion in the workplace.
13. GlaxoSmithKline has a robust pipeline of new drugs and treatments in development, with over 50 candidate therapies in various stages of clinical trials.
14. The company has a strong presence on social media, with over 85,000 followers on Twitter and active accounts on LinkedIn, Facebook, and Instagram.
15. GlaxoSmithKline has received numerous awards and recognition for its work, including being named one of the “World’s Most Ethical Companies” by the Ethisphere Institute for 11 consecutive years.
See Company Analysis
2. The company has a long history, dating back to a pharmacy opened by Joseph Nathan in New Zealand in 1830.
3. The company was formally founded in 1906 by Joseph Edward Nathan and his brother-in-law, Thomas Holloway, as a small pharmacy in London.
4. The name Glaxo comes from the first product that the company produced, which was a dried milk product called Glaxo.
5. Glaxo merged with Wellcome in 1995 to form Glaxo Wellcome, which then merged with SmithKline Beecham in 2000 to form GlaxoSmithKline.
6. GlaxoSmithKline is currently one of the largest pharmaceutical companies in the world, with revenue of over $41 billion in 2020.
7. The company is a major producer of vaccines, consumer healthcare products, and prescription medicines, and it has a presence in over 150 countries.
8. GlaxoSmithKline has a long history of significant scientific achievements, including the development of treatments for HIV, influenza, and malaria.
9. The company has also been involved in several high-profile legal cases, including a $3 billion settlement for illegally promoting certain drugs and a settlement with the US government for $750 million for manufacturing and quality control problems at a plant in Puerto Rico.
10. In 2020, GlaxoSmithKline became the first pharmaceutical company to pledge to make its carbon footprint net-zero by 2050.
11. GlaxoSmithKline has a strong commitment to corporate social responsibility, with a focus on improving global health, reducing its environmental impact, and supporting communities where it operates.
12. The company has a diverse workforce, with over 100,000 employees worldwide and a strong focus on diversity and inclusion in the workplace.
13. GlaxoSmithKline has a robust pipeline of new drugs and treatments in development, with over 50 candidate therapies in various stages of clinical trials.
14. The company has a strong presence on social media, with over 85,000 followers on Twitter and active accounts on LinkedIn, Facebook, and Instagram.
15. GlaxoSmithKline has received numerous awards and recognition for its work, including being named one of the “World’s Most Ethical Companies” by the Ethisphere Institute for 11 consecutive years.
See Company Analysis
Wait! There's more — sign up for free or log in